Jump to content

Reproducible Blood Marker


PressWatch

Recommended Posts

From Presswatch


This is evidence to support the case for a substance known as VEGF as representing a significant and reproducible marker for the sadly adverse indication in resected (ie surgically removed ) Pancreatic Cancer.


It is a literature review and statistical analysis of existing data conducted by a team including Prof John Neoptholemous ( Liverpool) who is generously providing valuable information and support to the PCUK funded 'Study for Survival'


(http://www.pancreaticcancer.org.uk/study_survival_home.htm )



Smith RA, Tang J, Tudur-Smith C, Neoptolemos JP, Ghaneh P. Related Articles


Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.

Br J Cancer. 2011 Mar 29;. [Epub ahead of print]

PMID: 21448172 [PubMed - as supplied by publisher]


Includes VEGF, p53, p16,Smad4,bcl.bax, EGFR

Link to comment
Share on other sites

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.